Trial Profile
Sexuality and Management of Benign Prostatic Hyperplasia With Alfuzosin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Sanofi
- 25 Jul 2009 New trial record